SIGLEC-10-ANTIKÖRPER

European patent · EP3377529 · Deleted

Register entry

Publication number
EP3377529
Application number
EP16797901
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 17, 2016
Published
Sep 26, 2018
Granted
Jul 21, 2021
Deleted
Jun 23, 2026
Reason
Annual fee unpaid
IPC classes
C07K 16/28 (2006.01)
C07K 14/705 (2006.01)
Priority
US 201562256188 P 17.11.2015
PCT application
PCT/EP2016/077955 17.11.2016
PCT publication
WO2017/085166 26.05.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 23, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.06.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.06.2026

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  5. Jun 1, 2022

    Change

    Published in Swissreg on 01.06.2022

  6. Jul 21, 2021

    Granted

    Published in Swissreg on 21.07.2021

Parties

Holder

Innate Pharma

117, Avenue de Luminy, 13009 Marseille, FR

Inventor

GAUTHIER, Laurent

13008 Marseille, FR

CORNEN, Stéphanie

13009 Marseille, FR

ROSSI, Benjamin

13008 Marseille, FR

WAGTMANN, Nicolai

13260 Cassis, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.